Skip to main content
Premium Trial:

Request an Annual Quote

BGI-Complete Genomics Deal Clears Last Regulatory Hurdle

NEW YORK (GenomeWeb News) – The State Administration of Foreign Exchange of the People's Republic of China has approved BGI's proposed $118 million acquisition of Complete Genomics, the companies said today, setting the stage for the completion of the acquisition.

The deal has now received all necessary regulatory approvals, BGI and Complete said. The Ministry of Commerce of the People's Republic of China approved the deal a few weeks ago, and US regulators cleared the deal in January.

The cash tender offer for the deal has been extended several times and is now set to expire at 11:59 PM EDT, March 14.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.